Loading…

Prognostic value of choroidal vascular index in determining response to intravitreal dexamethasone implant treatment used in refractory diabetic macular edema

To investigate the effect of intravitreal dexamethasone (IVD) implant injection, which was used in the treatment of DME, on CVI and to investigate whether CVI can be used as a prognostic marker in the treatment of anti-VEGF resistant DME. A retrospective observational and comparative study. Twenty-f...

Full description

Saved in:
Bibliographic Details
Published in:Lasers in medical science 2023-01, Vol.38 (1), p.47-47, Article 47
Main Authors: İlgüy, Serdar, Işık, Mehmed Uğur
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c256t-61c07e6ad622548c81cc1af37b78ca4bde875bf2eb25b7212ddcc9e34ea8d2e33
container_end_page 47
container_issue 1
container_start_page 47
container_title Lasers in medical science
container_volume 38
creator İlgüy, Serdar
Işık, Mehmed Uğur
description To investigate the effect of intravitreal dexamethasone (IVD) implant injection, which was used in the treatment of DME, on CVI and to investigate whether CVI can be used as a prognostic marker in the treatment of anti-VEGF resistant DME. A retrospective observational and comparative study. Twenty-five eyes of 25 patients with refractory diabetic macular edema who underwent intravitreal dexamethasone (IVD) implant and 50 eyes of 50 healthy patients were included in the study. Central macular thickness (CMT), subfoveal choroidal thickness (SFCT), luminal choroidal area (LCA), total choroidal area (TCA), stromal choroidal area (SCA), and choroidal vascularity index (CVI) were measured on optical coherence tomography. There was no significant difference between the groups in terms of age and gender. When the pre-treatment values in the IVD group were compared with the healthy group, LCA and SCA values were higher, and CVI ratios were lower in the IVD group compared to the control group. When baseline, 1st, and 3rd months after injection were compared, it was determined that there was a significant decrease in CMT and LCA. There was no statistically significant difference in SFCT, TCA, and CVI. There was a significant negative correlation between baseline CVI and 3rd month CMT after IVD (rho: − 0.643, p : 0.001). It was observed that the baseline and 1st month LCA values were significantly higher than the 3rd month. The choroidal vascular structure may be affected by IVD treatment. CVI may also have value as a prognostic marker in monitoring the response to treatment.
doi_str_mv 10.1007/s10103-023-03711-7
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2768233220</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2772189440</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-61c07e6ad622548c81cc1af37b78ca4bde875bf2eb25b7212ddcc9e34ea8d2e33</originalsourceid><addsrcrecordid>eNp9kU1PHiEQx4lpU1_aL-ChIenFy1ZedmE9NkariUk91MQbYWH2EbPAU2CNfhk_a9mutU0PPQCTmd_8Z8gfoUNKPlNC5HGmhBLeEFYPl5Q2cgft0ZZ3jSDt7Zu_4l20n_M9IVQKyt-hXS5ETwTne-j5OsVNiLk4gx_0NAOOIzZ3MUVn9VRT2cyTTtgFC4_1xhYKJO-CCxucIG9jyIBLrKWS9IMrCWpbZbWHcqdzDICd3046FLzUiocazRnsIpZgTNqUmJ6wdXqAZQuv14lgwev36O2opwwfXt4DdHN-9v30orn69vXy9MtVY1gnSiOoIRKEtoKxru1NT42heuRykL3R7WChl90wMhhYN0hGmbXGnABvQfeWAecH6GjV3ab4Y4ZclHfZwFT3hjhnxaToGeeMkYp--ge9j3MKdbtKVe3-pG0Xiq2USTHn-k-1Tc7r9KQoUYt7anVPVffUL_eUrE0fX6TnwYN9bfltVwX4CuRaChtIf2b_R_Yn5A6p-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2772189440</pqid></control><display><type>article</type><title>Prognostic value of choroidal vascular index in determining response to intravitreal dexamethasone implant treatment used in refractory diabetic macular edema</title><source>Springer Link</source><creator>İlgüy, Serdar ; Işık, Mehmed Uğur</creator><creatorcontrib>İlgüy, Serdar ; Işık, Mehmed Uğur</creatorcontrib><description>To investigate the effect of intravitreal dexamethasone (IVD) implant injection, which was used in the treatment of DME, on CVI and to investigate whether CVI can be used as a prognostic marker in the treatment of anti-VEGF resistant DME. A retrospective observational and comparative study. Twenty-five eyes of 25 patients with refractory diabetic macular edema who underwent intravitreal dexamethasone (IVD) implant and 50 eyes of 50 healthy patients were included in the study. Central macular thickness (CMT), subfoveal choroidal thickness (SFCT), luminal choroidal area (LCA), total choroidal area (TCA), stromal choroidal area (SCA), and choroidal vascularity index (CVI) were measured on optical coherence tomography. There was no significant difference between the groups in terms of age and gender. When the pre-treatment values in the IVD group were compared with the healthy group, LCA and SCA values were higher, and CVI ratios were lower in the IVD group compared to the control group. When baseline, 1st, and 3rd months after injection were compared, it was determined that there was a significant decrease in CMT and LCA. There was no statistically significant difference in SFCT, TCA, and CVI. There was a significant negative correlation between baseline CVI and 3rd month CMT after IVD (rho: − 0.643, p : 0.001). It was observed that the baseline and 1st month LCA values were significantly higher than the 3rd month. The choroidal vascular structure may be affected by IVD treatment. CVI may also have value as a prognostic marker in monitoring the response to treatment.</description><identifier>ISSN: 1435-604X</identifier><identifier>ISSN: 0268-8921</identifier><identifier>EISSN: 1435-604X</identifier><identifier>DOI: 10.1007/s10103-023-03711-7</identifier><identifier>PMID: 36680633</identifier><language>eng</language><publisher>London: Springer London</publisher><subject>Choroid ; Comparative studies ; Dentistry ; Dexamethasone ; Dexamethasone - pharmacology ; Diabetes ; Diabetes Mellitus ; Diabetic Retinopathy - diagnostic imaging ; Diabetic Retinopathy - drug therapy ; Edema ; Humans ; Injection ; Lasers ; Macular Edema - drug therapy ; Medicine ; Medicine &amp; Public Health ; Optical Devices ; Optics ; Original Article ; Photonics ; Prognosis ; Quantum Optics ; Retrospective Studies ; Statistical analysis ; Steroids ; Thickness ; Tomography, Optical Coherence ; Vascular endothelial growth factor</subject><ispartof>Lasers in medical science, 2023-01, Vol.38 (1), p.47-47, Article 47</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2023. corrected publication 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-61c07e6ad622548c81cc1af37b78ca4bde875bf2eb25b7212ddcc9e34ea8d2e33</cites><orcidid>0000-0002-5003-3834</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36680633$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>İlgüy, Serdar</creatorcontrib><creatorcontrib>Işık, Mehmed Uğur</creatorcontrib><title>Prognostic value of choroidal vascular index in determining response to intravitreal dexamethasone implant treatment used in refractory diabetic macular edema</title><title>Lasers in medical science</title><addtitle>Lasers Med Sci</addtitle><addtitle>Lasers Med Sci</addtitle><description>To investigate the effect of intravitreal dexamethasone (IVD) implant injection, which was used in the treatment of DME, on CVI and to investigate whether CVI can be used as a prognostic marker in the treatment of anti-VEGF resistant DME. A retrospective observational and comparative study. Twenty-five eyes of 25 patients with refractory diabetic macular edema who underwent intravitreal dexamethasone (IVD) implant and 50 eyes of 50 healthy patients were included in the study. Central macular thickness (CMT), subfoveal choroidal thickness (SFCT), luminal choroidal area (LCA), total choroidal area (TCA), stromal choroidal area (SCA), and choroidal vascularity index (CVI) were measured on optical coherence tomography. There was no significant difference between the groups in terms of age and gender. When the pre-treatment values in the IVD group were compared with the healthy group, LCA and SCA values were higher, and CVI ratios were lower in the IVD group compared to the control group. When baseline, 1st, and 3rd months after injection were compared, it was determined that there was a significant decrease in CMT and LCA. There was no statistically significant difference in SFCT, TCA, and CVI. There was a significant negative correlation between baseline CVI and 3rd month CMT after IVD (rho: − 0.643, p : 0.001). It was observed that the baseline and 1st month LCA values were significantly higher than the 3rd month. The choroidal vascular structure may be affected by IVD treatment. CVI may also have value as a prognostic marker in monitoring the response to treatment.</description><subject>Choroid</subject><subject>Comparative studies</subject><subject>Dentistry</subject><subject>Dexamethasone</subject><subject>Dexamethasone - pharmacology</subject><subject>Diabetes</subject><subject>Diabetes Mellitus</subject><subject>Diabetic Retinopathy - diagnostic imaging</subject><subject>Diabetic Retinopathy - drug therapy</subject><subject>Edema</subject><subject>Humans</subject><subject>Injection</subject><subject>Lasers</subject><subject>Macular Edema - drug therapy</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Optical Devices</subject><subject>Optics</subject><subject>Original Article</subject><subject>Photonics</subject><subject>Prognosis</subject><subject>Quantum Optics</subject><subject>Retrospective Studies</subject><subject>Statistical analysis</subject><subject>Steroids</subject><subject>Thickness</subject><subject>Tomography, Optical Coherence</subject><subject>Vascular endothelial growth factor</subject><issn>1435-604X</issn><issn>0268-8921</issn><issn>1435-604X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kU1PHiEQx4lpU1_aL-ChIenFy1ZedmE9NkariUk91MQbYWH2EbPAU2CNfhk_a9mutU0PPQCTmd_8Z8gfoUNKPlNC5HGmhBLeEFYPl5Q2cgft0ZZ3jSDt7Zu_4l20n_M9IVQKyt-hXS5ETwTne-j5OsVNiLk4gx_0NAOOIzZ3MUVn9VRT2cyTTtgFC4_1xhYKJO-CCxucIG9jyIBLrKWS9IMrCWpbZbWHcqdzDICd3046FLzUiocazRnsIpZgTNqUmJ6wdXqAZQuv14lgwev36O2opwwfXt4DdHN-9v30orn69vXy9MtVY1gnSiOoIRKEtoKxru1NT42heuRykL3R7WChl90wMhhYN0hGmbXGnABvQfeWAecH6GjV3ab4Y4ZclHfZwFT3hjhnxaToGeeMkYp--ge9j3MKdbtKVe3-pG0Xiq2USTHn-k-1Tc7r9KQoUYt7anVPVffUL_eUrE0fX6TnwYN9bfltVwX4CuRaChtIf2b_R_Yn5A6p-w</recordid><startdate>20230121</startdate><enddate>20230121</enddate><creator>İlgüy, Serdar</creator><creator>Işık, Mehmed Uğur</creator><general>Springer London</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7SP</scope><scope>7U5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H8D</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>L7M</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5003-3834</orcidid></search><sort><creationdate>20230121</creationdate><title>Prognostic value of choroidal vascular index in determining response to intravitreal dexamethasone implant treatment used in refractory diabetic macular edema</title><author>İlgüy, Serdar ; Işık, Mehmed Uğur</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-61c07e6ad622548c81cc1af37b78ca4bde875bf2eb25b7212ddcc9e34ea8d2e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Choroid</topic><topic>Comparative studies</topic><topic>Dentistry</topic><topic>Dexamethasone</topic><topic>Dexamethasone - pharmacology</topic><topic>Diabetes</topic><topic>Diabetes Mellitus</topic><topic>Diabetic Retinopathy - diagnostic imaging</topic><topic>Diabetic Retinopathy - drug therapy</topic><topic>Edema</topic><topic>Humans</topic><topic>Injection</topic><topic>Lasers</topic><topic>Macular Edema - drug therapy</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Optical Devices</topic><topic>Optics</topic><topic>Original Article</topic><topic>Photonics</topic><topic>Prognosis</topic><topic>Quantum Optics</topic><topic>Retrospective Studies</topic><topic>Statistical analysis</topic><topic>Steroids</topic><topic>Thickness</topic><topic>Tomography, Optical Coherence</topic><topic>Vascular endothelial growth factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>İlgüy, Serdar</creatorcontrib><creatorcontrib>Işık, Mehmed Uğur</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Aerospace Database</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Lasers in medical science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>İlgüy, Serdar</au><au>Işık, Mehmed Uğur</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic value of choroidal vascular index in determining response to intravitreal dexamethasone implant treatment used in refractory diabetic macular edema</atitle><jtitle>Lasers in medical science</jtitle><stitle>Lasers Med Sci</stitle><addtitle>Lasers Med Sci</addtitle><date>2023-01-21</date><risdate>2023</risdate><volume>38</volume><issue>1</issue><spage>47</spage><epage>47</epage><pages>47-47</pages><artnum>47</artnum><issn>1435-604X</issn><issn>0268-8921</issn><eissn>1435-604X</eissn><abstract>To investigate the effect of intravitreal dexamethasone (IVD) implant injection, which was used in the treatment of DME, on CVI and to investigate whether CVI can be used as a prognostic marker in the treatment of anti-VEGF resistant DME. A retrospective observational and comparative study. Twenty-five eyes of 25 patients with refractory diabetic macular edema who underwent intravitreal dexamethasone (IVD) implant and 50 eyes of 50 healthy patients were included in the study. Central macular thickness (CMT), subfoveal choroidal thickness (SFCT), luminal choroidal area (LCA), total choroidal area (TCA), stromal choroidal area (SCA), and choroidal vascularity index (CVI) were measured on optical coherence tomography. There was no significant difference between the groups in terms of age and gender. When the pre-treatment values in the IVD group were compared with the healthy group, LCA and SCA values were higher, and CVI ratios were lower in the IVD group compared to the control group. When baseline, 1st, and 3rd months after injection were compared, it was determined that there was a significant decrease in CMT and LCA. There was no statistically significant difference in SFCT, TCA, and CVI. There was a significant negative correlation between baseline CVI and 3rd month CMT after IVD (rho: − 0.643, p : 0.001). It was observed that the baseline and 1st month LCA values were significantly higher than the 3rd month. The choroidal vascular structure may be affected by IVD treatment. CVI may also have value as a prognostic marker in monitoring the response to treatment.</abstract><cop>London</cop><pub>Springer London</pub><pmid>36680633</pmid><doi>10.1007/s10103-023-03711-7</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-5003-3834</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1435-604X
ispartof Lasers in medical science, 2023-01, Vol.38 (1), p.47-47, Article 47
issn 1435-604X
0268-8921
1435-604X
language eng
recordid cdi_proquest_miscellaneous_2768233220
source Springer Link
subjects Choroid
Comparative studies
Dentistry
Dexamethasone
Dexamethasone - pharmacology
Diabetes
Diabetes Mellitus
Diabetic Retinopathy - diagnostic imaging
Diabetic Retinopathy - drug therapy
Edema
Humans
Injection
Lasers
Macular Edema - drug therapy
Medicine
Medicine & Public Health
Optical Devices
Optics
Original Article
Photonics
Prognosis
Quantum Optics
Retrospective Studies
Statistical analysis
Steroids
Thickness
Tomography, Optical Coherence
Vascular endothelial growth factor
title Prognostic value of choroidal vascular index in determining response to intravitreal dexamethasone implant treatment used in refractory diabetic macular edema
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T14%3A22%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20value%20of%20choroidal%20vascular%20index%20in%20determining%20response%20to%20intravitreal%20dexamethasone%20implant%20treatment%20used%20in%20refractory%20diabetic%20macular%20edema&rft.jtitle=Lasers%20in%20medical%20science&rft.au=%C4%B0lg%C3%BCy,%20Serdar&rft.date=2023-01-21&rft.volume=38&rft.issue=1&rft.spage=47&rft.epage=47&rft.pages=47-47&rft.artnum=47&rft.issn=1435-604X&rft.eissn=1435-604X&rft_id=info:doi/10.1007/s10103-023-03711-7&rft_dat=%3Cproquest_cross%3E2772189440%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c256t-61c07e6ad622548c81cc1af37b78ca4bde875bf2eb25b7212ddcc9e34ea8d2e33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2772189440&rft_id=info:pmid/36680633&rfr_iscdi=true